Back to Search
A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 18- to 30-Year-Old Healthy Adults
Hollywood, Florida, 33024
Savannah, Georgia, 31406
Sioux City, Iowa, 51106
Lenexa, Kansas, 66219
Worcester, Massachusetts, 01655
Savannah, Georgia, 31406
Sioux City, Iowa, 51106
Lenexa, Kansas, 66219
Worcester, Massachusetts, 01655
Search ended 06/24/2023
The main objective of this trial is to evaluate the safety and reactogenicity of mRNA-1189 in 18- to 30-year-old healthy adults.
Eligibility
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, learn about Clinical
| Ages Eligible for Study | Min Age: 18 Years - Max Age: 30 Years |
| Sexes Eligible for Study | All |
| Accepts Healthy Volunteers | Yes |
Visit ClinicalTrials.Gov for more information
Support nonprofit organizations through participating in clinical trials at no cost to you
You may also be interested in
Cincinnati, Ohio and more
A Study Looking at the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults at Risk for SARS-CoV-2
SARS-CoV Infection and more Read more
Culver City, California
A Home-based Study Using Mobile Technology to Test Whether BI 1358894 is Effective in People With Depression
Major Depressive Disorder Read more
Pelham, Alabama and more